Author
Prem Kumar with profound experience and sound knowledge across a wide range of market forecasting methods, demand f.....
Chondroitin Sulfate Market: By Source, By Form, By Distribution Channel, By Application and Geography
Chondroitin Sulfate Market size was estimated at US$ x million in 2023 and is poised to grow at a CAGR of x% from 2024-2030. Chondroitin sulphate is a sulfated glycosaminoglycan (GAG) made up of alternating sugars like N-acetylgalactosamine and glucuronic acid in a chain. Chondroitin sulphate is a naturally occurring chemical component of human connective tissues that is present in cartilage around bone joints. Chondroitin sulphate is typically made from animal sources such bovine, porcine, shark, and other marine animals. Chondroitin Sulfate Market is a supplement that can help decrease the course of osteoarthritis while also reducing inflammation and pain. Joint function improves as a result of this. Chondroitin sulphate is frequently combined with glucosamine. Chondroitin sulphate is also used as an eye drop for irritated eyes, and it has veterinary use as well. Chondroitin sulfate is popular supplements used to treat the pain and loss of function associated with osteoarthritis (OA). It may also help prevent cartilage breakdown from osteoarthritis. Many clinical studies have found that chondroitin can reduce joint pain and stiffness in people with osteoarthritis. About 53 percent trusted source of people who take chondroitin have a 20 percent or greater improvement in knee pain.
Chondroitin sulfate may cause a number of side effects. Possible side effects and potential health risks are noticed. Chondroitin sulfate is naturally present in the cartilage surrounding your joints. The chondroitin sulfate found in dietary supplements is usually produced from animal sources, such as cow cartilage. Mild stomach pain and nausea are the two side effects most frequently caused by chondroitin sulfate. Global chondroitin sulfate market is surging owing to frequent acquisitions and launchings by the market players. For Instance, in 2017, BSA Institute Biochimique SA conducted a clinical trial using Chondroitin vs Celecoxib vs Placebo Trial. The institute named the trial as CONCEPT. This trial showed that, pharmaceutical-grade chondroitin sulfate was effective as an anti-inflammatory drug when compared to Placebo Trial and Celecoxib. The trial also revealed that, chondroitin sulfate is effective for reducing joint pain and increasing the functionality of the joints among knee osteoarthritis patient.
Study Period
2024-2030Base Year
2023CAGR
X%Largest Market
Asia-PacificFastest Growing Market
North America
Factors such as increasing geriatric populations, growing applications in joint health supplements and rising health consciousness among people are favouring the market. However, fluctuating raw material prices and reactions caused such as skin rashes are hampering the market.
Report Benchmarks |
Details |
Report Study Period |
2024-2030 |
Market CAGR |
X% |
By Source |
|
By Form |
|
By Distribution Channel |
|
By Application |
|
Download Free Sample Report
The key segments covered in the chondroitin sulfate market are: by source, form, distribution channel, application, and geography
The chondroitin sulfate market has been classified into North America, Asia Pacific, Europe, Latin America, Middle East and Africa, and the rest of MEA.
The chondroitin sulfate market key players are: Hebei, Sanxin Industrial Group, TSI Group Ltd., Qingdao Wan toulmin Biological Products Co., Ltd, Sigma-Aldrich, Inc., TSI Group Ltd.
Table of Content
Key Market Players